OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Con.

Sorry, there's nothing here.

Cite this paper

@article{Siegel2017OnabotulinumtoxinAIP, title={OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Con.}, author={Steven W. Siegel}, journal={The Journal of urology}, year={2017}, volume={197 1}, pages={11-13} }